Inventor · disambiguated record
Aarron T. Willingham
Also filed as: WILLINGHAM AARRON · WILLINGHAM AARRON T
13 granted patents·5 pending applications·109 citations·filing 1999–2023
91Inventor score
Files withSIRNA THERAPEUTICS INC8MERCK SHARP & DOHME LLC3UNIV CALIFORNIA3CANCILLA MARK1CARR BRIAN ALLEN1
Top patents by PatentIndex Score
18 records- 0194US9970005B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 15, 2018·15 cites·41 claims
- 0293US11932854B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·2 cites·25 claims
- 0392US9260471B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)CANCILLA MARK·Filed 2011·Granted Feb 16, 2016·60 cites·53 claims
- 0491US11193126B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2018·Granted Dec 7, 2021·7 cites·40 claims
- 0591US10689648B2Short interfering nucleic acid (siNA) compositionsSIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 23, 2020·5 cites·19 claims
- 0683US11530407B2Short interfering nucleic acid (siNA) compositionsSIRNA THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·1 cites·25 claims
- 0783US9243246B2Single-stranded RNAi agents containing an internal, non-nucleic acid spacerLIM LEE·Filed 2011·Granted Jan 26, 2016·11 cites·25 claims
- 0882US10584335B2Single-stranded RNAi agents containing an internal, non-nucleic acid spacerSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·3 cites·22 claims
- 0980US12486503B2Short interfering nucleic acid (siNA) compositionsSIRNA THERAPEUTICS INC·Filed 2022·Granted Dec 2, 2025·0 cites·18 claims
- 1080US9845466B2Single-stranded RNAi agents containing an internal, non-nucleic acid spacerSIRNA THERAPEUTICS INC·Filed 2015·Granted Dec 19, 2017·3 cites·26 claims
- 1171US2024101631A1Human interleukin-2 conjugates biased for the interleukin-2 receptor beta-gammac dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1265US11827684B2Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 28, 2023·0 cites·54 claims
- 1361US2015299696A1SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONSCARR BRIAN ALLEN·Filed 2013·Application pending·0 cites
- 1459US7867721B2In vitro method for identifying a compound using an eukaryotic mechanosensory transduction channelUNIV CALIFORNIA·Filed 2007·Granted Jan 11, 2011·0 cites·7 claims
- 1557US2003152991A1Eukaryotic mechanosensory transduction channelUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 1654US2024255492A1Functional cell-based potency assay for measuring biological activity of interleukin 2 (il-2) analogsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1740US2017097333A1Cell based assay to measure the t-cell stimulating capacity of anti-lag3 antibodies and other agentsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 1839US6537778B1Eukaryotic mechanosensory transduction channelUNIV CALIFORNIA·Filed 1999·Granted Mar 25, 2003·2 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Aarron T. Willingham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →